Clinical Trial Update: Phase I/IIa Study: RR001 Administered Following Chemotherapy Cycles for Patients With Locally Advanced Pancreatic Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/IIa clinical trial of RR001 for locally advanced pancreatic adenocarcinoma is currently recruiting after chemotherapy cycles.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• RR001

Snippet

Sponsor: EIR Biotherapies s.r.l. | Conditions: Locally Advanced Pancreatic Adenocarcinoma | Phase 1, Phase 2 | Status: RECRUITING